Rahway, NJ, United States of America

Nicolas Lachance

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicolas Lachance. Retrieved from https://idiyas.com/inventor/nicolas-lachance-eq9s6lh5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nicolas Lachance - Innovator in Prostaglandin E Inhibition

Introduction:

Nicolas Lachance, an accomplished inventor based in Rahway, NJ, has made significant strides in the field of pharmaceuticals. With a focus on improving treatment methods, his work revolves around innovative approaches that have potential implications for medical practices.

Latest Patents:

Lachance holds a patent titled "Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore." This patent represents a breakthrough in the understanding and application of prostaglandin E inhibitors, providing new avenues for treatment options.

Career Highlights:

Throughout his career, Nicolas has demonstrated a commitment to developing novel solutions within the pharmaceutical field. His expertise has allowed him to contribute to advancements that may enhance therapeutic efficacy.

Collaborations:

Lachance has worked alongside notable professionals in his field, including Michel Gallant and Marc Labelle. Their collaboration signifies the importance of teamwork in driving innovation and tackling complex challenges in research.

Conclusion:

Nicolas Lachance exemplifies the spirit of innovation in the pharmaceutical industry. By focusing on effective treatment methods for medical conditions, he continues to pave the way for new improvements that could benefit patients globally. His dedication to invention serves as an inspiration for fellow inventors and researchers in their pursuit of significant advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…